Keywords: wyeth, viviant, fails, match, lilly, evista, drug

Wyeth's Viviant fails to match Lilly's Evista

Article | 22 September 2008

Print This

US drug major Wyeth presented disappointing data on its osteoperosis treatment Viviant (bazedoxifene) at the American Society of Bone and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in